Navigation Links
New genetic test can detect clam disease

A sensitive new genetic test can now detect a crippling disease called QPX occurring in clam beds from Cape Cod south to Virginia and north to Canada. Although it does not affect humans and it is not as well known as red tide, the disease can have a significant impact on a local economy by killing clams and devastating shellfish harvests and commercial aquaculture operations.

QPX - for quahog parasite unknown - is a single-celled organism related to slime mold. It was first detected in 1995 in Provincetown, MA and spread to nearby clam beds, killing nine of ten clams in many of the beds. The disease spreads from clam to clam, infecting the clam by secreting a thick mucus layer to insulate itself from the clam's immune system.

Rebecca Gast, an associate scientist in the Biology Department at Woods Hole Oceanographic Institution (WHOI), has developed a genetic test to detect the organism not only in clams but in seawater and sediment. Since QPX also decomposes seaweed, researchers now believe it can be found in all coastal waters but doesn't become deadly to clams until it reaches a critical concentration in the water.

Gast notes that although red tide got a lot of media attention this year, QPX is actually a bigger problem. The toxins that cause red tide in clams and other shellfish in New England do not kill the shellfish and will wash away once the red tide bloom diminishes, eventually making the shellfish safe to eat. QPX kills the clams, and there is no known cure.

Gast is working with Roxanna Smolowitz, a veterinarian at the nearby Marine Biological Laboratory, to find out what triggers the organisms to reach concentrations that become deadly, and whether that threshold varies among clam strains. Smolowitz uses traditional microscopic examination of tissues to determine if clams are sick.

Gast's genetic test can now also be used to ensure clams without visible symptoms are not carrying the disease. With the disease sprea ding along the East Coast and no cure, the researchers say the best solution for shellfishermen and aquaculture operations is to keep infection levels as low as possible and try to keep seed clams free of the disease. One possible remedy may be rotating shellfish crops, much like farmers do on land.


Source:Woods Hole Oceanographic Institution

Related biology news :

1. Its not all genetic: Common epigenetic problem doubles cancer risk in mice
2. Scientists detect probable genetic cause of some Parkinsons disease cases
3. Mouse brain tumors mimic those in human genetic disorder
4. Scientists identify genetic pathways essential to RNA interference
5. Researchers trace evolution to relatively simple genetic changes
6. Key mechanism in genetic inheritance during cell division identified
7. Scientists identify genetic pathways essential to RNA interference
8. MUHC scientists describe genetic resistance to rampant virus
9. Mosaic mouse technique offers a powerful new tool to study diseases and genetics
10. Montreal researchers probe the genetic basis of memory
11. Biologists determine genetic blueprint of social amoeba
Post Your Comments:

(Date:6/2/2016)... , June 2, 2016 Perimeter ... Platforms, Unmanned Systems, Physical Infrastructure, Support & Other Service  ... visiongain offers comprehensive analysis of the global ... market will generate revenues of $17.98 billion in 2016. ... DVTEL Inc, a leader in software and hardware technologies ...
(Date:5/16/2016)... 2016   EyeLock LLC , a market leader ... of an IoT Center of Excellence in ... development of embedded iris biometric applications. EyeLock,s ... and security with unmatched biometric accuracy, making it the ... DNA. EyeLock,s platform uses video technology to deliver a ...
(Date:4/28/2016)... FRANCISCO and BANGALORE, India , ... of EdgeVerve Systems, a product subsidiary of Infosys (NYSE: ... provider, today announced a global partnership that will ... way to use mobile banking and payment services. ... is a key innovation area for financial services, but it ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... , June 23, 2016 /PRNewswire/ - FACIT ... Ontario biotechnology company, Propellon Therapeutics ... development and commercialization of a portfolio of first-in-class ... Epigenetic targets such as WDR5 represent an exciting ... significantly in precision medicine for cancer patients. Substantial ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... and Mold) microbial test has received AOAC Research Institute approval 061601. , “This ... introduced last year,” stated Bob Salter, Vice President of Regulatory and Industrial Affairs. ...
(Date:6/23/2016)... --  EpiBiome , a precision microbiome engineering company, today ... from Silicon Valley Bank (SVB). The financing will allow ... drug development efforts, as well as purchase additional lab ... been an incredible strategic partner to us – one ... provide," said Dr. Aeron Tynes Hammack , EpiBiome,s ...
(Date:6/23/2016)... ... June 23, 2016 , ... In a new case report ... detail how a patient who developed lymphedema after being treated for breast cancer benefitted ... change the paradigm for dealing with this debilitating, frequent side effect of cancer treatment. ...
Breaking Biology Technology: